{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:04:17Z","timestamp":1790129057195,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006458","name":"The Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e00976","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:09:44Z","timestamp":1785222584000},"page":"e00976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing"],"prefix":"10.1016","volume":"23","author":[{"given":"Yichuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank D.","family":"Mentch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh","family":"Ostberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Glessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurot.2026.e00976_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00976_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurot.2026.e00976_bib3","series-title":"Proceedings of a workshop","year":"2017"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00976_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40262-018-0632-y","article-title":"Clinical pharmacokinetics and pharmacodynamics of drugs in the central nervous system","volume":"57","author":"Srinivas","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00976_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00976_bib6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/jnnp-2019-320879","article-title":"Drug repurposing in neurological diseases: an integrated approach to reduce trial and error","volume":"90","author":"Clout","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00976_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.tips.2019.06.003","article-title":"Insights into computational drug repurposing for neurodegenerative disease","volume":"40","author":"Paranjpe","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00976_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/neuonc\/noab274","article-title":"Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors","volume":"24","author":"Doz","year":"2022","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00976_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00976_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-021-07889-3","article-title":"Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis","volume":"21","author":"Khan","year":"2021","journal-title":"BMC Cancer"},{"issue":"7818","key":"10.1016\/j.neurot.2026.e00976_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","article-title":"Expanded encyclopaedias of DNA elements in the human and mouse genomes","volume":"583","author":"Consortium","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00976_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tins.2018.11.002","article-title":"The Role of De Novo Noncoding Regulatory Mutations in Neurodevelopmental Disorders","volume":"42","author":"Turner","year":"2019","journal-title":"Trends Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00976_bib13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41588-019-0420-0","article-title":"Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk","volume":"51","author":"Zhou","year":"2019","journal-title":"Nat Genet"},{"issue":"D1","key":"10.1016\/j.neurot.2026.e00976_bib14","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00976_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00976_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10 years of GWAS discovery: biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"6301","key":"10.1016\/j.neurot.2026.e00976_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.neurot.2026.e00976_bib18","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2147\/CMAR.S173323","article-title":"Bevacizumab combined with chemotherapy vs single-agent therapy in recurrent glioblastoma: evidence from randomized controlled trials","volume":"10","author":"Chen","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00976_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13046-017-0606-1","article-title":"beta-catenin-mediated YAP signaling promotes human glioma growth","volume":"36","author":"Wang","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00976_bib20","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","article-title":"YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial","volume":"31","author":"Yap","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00976_bib21","article-title":"Suppression of adiponectin receptor 1 promotes memory dysfunction and Alzheimer's disease-like pathologies","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e00976_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2018.05.008","article-title":"Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis","volume":"238","author":"Cao","year":"2018","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00976_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrg.2017.38","article-title":"Network propagation: a universal amplifier of genetic associations","volume":"18","author":"Cowen","year":"2017","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00976_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1532","article-title":"Splicing and neurodegeneration: insights and mechanisms","volume":"10","author":"Nik","year":"2019","journal-title":"Wiley Interdiscip Rev RNA"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:09:55Z","timestamp":1790125795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926001467"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00976","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00976"}}